Clik here to view.
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Paricalcitol Injection in...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, 10 mcg,...
View ArticleClik here to view.
Clik here to view.
生物制药业认为，联合国药品可及性高级别小组的建议错失了真正回应患者需求的良机
日内瓦 –(美国商业资讯)–生物制药业认为，在应对影响数百万人能否获取他们需要的药品及疫苗的紧要议题上，联合国药品可及性高级别小组(UN High Level Panel on Access to Medicines,...
View ArticleClik here to view.
GORE® TAG®胸主动脉血管内覆膜支架的枢纽性研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，GORE® TAG®胸主动脉血管内覆膜支架(TBE)的枢纽性研究完成首例植入。入组该例患者的是Himanshu Patel, MD，他是密西根大学佛兰克尔心血管中心成人心脏外科的分科主任和该研究的联席全国主要研究者。 Smart News...
View ArticleClik here to view.
Takeda and Zydus Cadila partner to address the global threat of Chikungunya
OSAKA, Japan & AHMEDABAD, India Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease...
View ArticleClik here to view.
One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN®...
FLAGSTAFF, Ariz. & LAS VEGAS W. L. Gore & Associates, Inc. (Gore) today announced positive results from a prospective, multicenter Investigational Device Exemption (IDE) Clinical Study of...
View ArticleClik here to view.
GORE® VIABAHN® Endoprosthesisが複雑なSFA疾患の治療で最適なデバイスであることを日本での臨床研究の1年成績が確認
米アリゾナ州フラッグスタッフ & ラスベガス （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® VIABAHN® Endoprosthesis with Heparin Bioactive...
View ArticleClik here to view.
日本临床研究1年结果证实，GORE® VIABAHN®血管内覆膜支架是治疗SFA复杂型病变的首选器械
亚利桑那州弗拉格斯塔夫和拉斯维加斯 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天发布了配备肝素生物活性涂层*的GORE®...
View ArticleClik here to view.
Acelity Announces Early Tender Results for the Exchange Offer and Successful...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the results, as of 5:00 p.m., New York City time, on September 19, 2016...
View ArticleClik here to view.
Takeda and Affilogic enter into Research Collaboration to Develop...
OSAKA, Japan & NANTES, France Takeda Pharmaceutical Company Limited (TSE: 4502) and Affilogic today jointly announced that the companies have entered into a research collaboration to explore...
View ArticleClik here to view.
サンバイオ、日本における外傷性脳損傷を対象としたフェーズ２臨床試験開始のお知らせ
東京 （ビジネスワイヤ） — サンバイオ株式会社（本社:東京都中央区、代表取締役社長：森 敬太）は、本日、神経系疾患を対象に日米で開発を進めている再生細胞薬SB623（以下、「本剤」）の外傷性脳損傷を対象としたフェーズ２臨床試験を国内で開始しましたので、お知らせします。...
View ArticleClik here to view.
施乐辉公司在世界伤口愈合学会联盟会议(WUWHS)上加强对高级伤口处治宣教的坚定承诺
伦敦 (美国商业资讯) — 全球性医疗技术巨头施乐辉公司(LSE:SN) (NYSE:SNN)在2016年9月25-29日于意大利佛罗伦萨召开的世界伤口愈合学会联盟会议(WUWHS)上赞助了3场科学研讨会。这些研讨会加强了施乐辉公司的承诺，即通过开展并有效传播能为患者提供更佳转归的临床实践领域的研究来支持医疗保健专业人员。...
View ArticleClik here to view.
GORE® TAG® Thoracic Branch Endoprosthesisのピボタル試験で初の植え込みが完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、ピボタル試験でGORE® TAG® Thoracic Branch...
View ArticleClik here to view.
SanBio Begins Clinical Trial of Regenerative Cell Medicine for Patients with...
MOUNTAIN VIEW, Calif. SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, announced today that it has begun a Phase 2 clinical trial of regenerative cell...
View ArticleClik here to view.
SAB Biotherapeutics的免疫治疗药物提案跻身WHO报告中的顶级平台技术解决方案之列
马里兰州贝塞斯达和南达科他州苏福尔斯 (美国商业资讯) — 临床阶段生物制药开发企业SAB Biotherapeutics (SAB)今天宣布，其DiversitAb人类抗体生产平台被确认为世界卫生组织(WHO)针对有大流行可能的优先感染性疾病的平台技术公开磋商中涌现的6个最有价值提案之一，该平台发挥了转染色体牛(Tc Bovine™)的优势。...
View ArticleClik here to view.
Gyros Protein Technologies Establishes Dedicated Office in Japan
UPPSALA, Sweden Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has established a...
View ArticleClik here to view.
Clik here to view.
GE Healthcare Aims to Fund up to $50M for Global Health Startups
BANGALORE, India GE Healthcare, the $18 billion healthcare technology division of GE (NYSE: GE), today announced the launch of the company’s first healthcare accelerator, five.eight, aimed at...
View ArticleClik here to view.
Alexion Employees Volunteer Together in Company’s First Global Day of Service
NEW HAVEN, Conn. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of the Company’s...
View Article